vimarsana.com

Latest Breaking News On - Vaxart pharmaceuticals - Page 1 : vimarsana.com

Filgotinib drops out of US arthritis race: Gilead ends bid for FDA approval

Filgotinib drops out of US arthritis race: Gilead ends bid for FDA approval Disclosures: Singh reports consulting fees from Clearview healthcare partners, Clinical Care Options, Crealta/Horizon, Fidia, Focus Forward, Medisys, Medscape, Navigant Consulting, Practice Point Communications, Putnam Associates, Spherix, Trio health, UBM, WebMD, the NIH and the American College of Rheumatology, as well as stock option ownership with Charlotte’s Web Holdings and Vaxart Pharmaceuticals, and speaker’s bureau membership with Simply Speaking. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.